Sponsor pipeline

Saad A Khan clinical trial pipeline

Get alerts when Saad A Khan's trials change

1 active trials 0 recruiting 1 disease areas 5 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-10
Enrollment reduced: 12 → 9 participants
Sponsor changed: Stanford University → Saad A Khan
Results posted: 2026-09-09
Interventions modified
Completion pushed: 2026-09-01 → 2027-07
NCT05119296 Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced… · Phase 2

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT05119296 Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced… Thyroid Cancer Active, Not Recruiting 2026-09-09

Disease areas by active trials

Thyroid Cancer (1)

Get alerts when Saad A Khan's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free